LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 38 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,905 | -66.2% | 17,191 | -73.2% | 0.00% | – |
Q2 2023 | $200,639 | +93.7% | 64,102 | +180.3% | 0.00% | – |
Q1 2023 | $103,606 | +39144.7% | 22,871 | +35635.9% | 0.00% | – |
Q4 2022 | $264 | – | 64 | +2033.3% | 0.00% | – |
Q3 2022 | $0 | – | 3 | -98.6% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 213 | -99.8% | 0.00% | – |
Q1 2022 | $471,000 | -39.8% | 116,223 | +60.3% | 0.00% | – |
Q4 2021 | $782,000 | -17.2% | 72,510 | -11.4% | 0.00% | – |
Q3 2021 | $944,000 | +1352.3% | 81,810 | +1133.2% | 0.00% | – |
Q2 2021 | $65,000 | -92.5% | 6,634 | -88.9% | 0.00% | – |
Q1 2021 | $872,000 | +1094.5% | 59,700 | +1641.5% | 0.00% | – |
Q4 2020 | $73,000 | -90.2% | 3,428 | -93.0% | 0.00% | – |
Q3 2020 | $744,000 | +2088.2% | 49,047 | +1767.7% | 0.00% | – |
Q2 2020 | $34,000 | – | 2,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,515,148 | $32,439,000 | 9.14% |
ACUTA CAPITAL PARTNERS, LLC | 863,100 | $18,479,000 | 5.03% |
SILVERARC CAPITAL MANAGEMENT, LLC | 217,203 | $4,650,000 | 2.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,144,539 | $110,145,000 | 2.18% |
Atlas Venture Advisors, Inc. | 292,184 | $6,256,000 | 1.40% |
Logos Global Management LP | 715,000 | $15,308,000 | 1.31% |
Sio Capital Management, LLC | 188,661 | $4,039,000 | 0.83% |
Vivo Capital, LLC | 799,662 | $17,121,000 | 0.76% |
Altium Capital Management LP | 93,261 | $1,997,000 | 0.75% |
RA Capital Management | 1,515,151 | $32,439,000 | 0.45% |